1. Home
  2. DEI vs NVCR Comparison

DEI vs NVCR Comparison

Compare DEI & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Douglas Emmett Inc.

DEI

Douglas Emmett Inc.

HOLD

Current Price

$12.38

Market Cap

1.8B

Sector

Real Estate

ML Signal

HOLD

Logo NovoCure Limited

NVCR

NovoCure Limited

HOLD

Current Price

$18.09

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DEI
NVCR
Founded
1971
2000
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
2.0B
IPO Year
2006
2015

Fundamental Metrics

Financial Performance
Metric
DEI
NVCR
Price
$12.38
$18.09
Analyst Decision
Hold
Buy
Analyst Count
8
6
Target Price
$12.94
$28.08
AVG Volume (30 Days)
2.2M
1.8M
Earning Date
05-05-2026
04-30-2026
Dividend Yield
7.06%
N/A
EPS Growth
N/A
21.79
EPS
N/A
N/A
Revenue
$1,003,982,000.00
$655,353,000.00
Revenue This Year
$1.70
$7.72
Revenue Next Year
$2.35
$6.74
P/E Ratio
N/A
N/A
Revenue Growth
1.77
8.28
52 Week Low
$9.04
$9.82
52 Week High
$16.94
$20.55

Technical Indicators

Market Signals
Indicator
DEI
NVCR
Relative Strength Index (RSI) 53.87 59.61
Support Level $11.15 $12.85
Resistance Level $12.70 $18.48
Average True Range (ATR) 0.41 1.11
MACD -0.02 0.24
Stochastic Oscillator 52.24 51.76

Price Performance

Historical Comparison
DEI
NVCR

About DEI Douglas Emmett Inc.

Douglas Emmett Inc is an integrated, self-administered, and self-managed REIT. The group focuses on owning, acquiring, developing, and managing a substantial market share of office properties and multifamily communities in neighborhoods with supply constraints, high-end executive housing, and key lifestyle amenities. Its properties are located in the Beverly Hills, Brentwood, Burbank, Century City, Olympic Corridor, Santa Monica, Sherman Oaks/Encino, Warner Center/Woodland Hills and Westwood submarkets of Los Angeles County, California, and in Honolulu, Hawaii. It has two business segments: the office segment and multifamily segment, of which Office segment derives maximum revenue.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.

Share on Social Networks: